Working together to develop a screening platform to enhance the detection and management of Alzheimer’s disease.
PREDICTOM is an international across sector initiative to bring dementia diagnostics closer to the public through a customisable cognitive and biomarker screening platform.
Latest news
News
📱BrainCheck and the Future of Brain Health: Making It Simple
What if checking your brain health was as easy as a quick test on your phone or tablet? For millions worried about memory slips, that could be life-changing. Thanks to BrainCheck, this isn’t a dream—it’s happening now.
News
🏧Banking on Brain Health: How a Simple App Could Support Early Detection of Cognitive Decline
Could forgetting a PIN be more than a simple slip? Scientists behind the Banking App believe that subtle changes in how we handle financial tasks may signal early cognitive decline, including Alzheimer’s disease. By simulating ATM interactions, the app captures detailed performance metrics—such as speed, accuracy, and error patterns—that researchers use to study functional changes before traditional symptoms appear.
News
👁️🗨️Eyes on the Future: How Eye-Tracking Could Transform Early Dementia Detection
Eye-tracking technology is emerging as a promising tool for early detection of cognitive decline. By analyzing involuntary eye movements, researchers can identify subtle cognitive and attentional changes that may accompany the earliest stages of mild cognitive impairment and Alzheimer’s disease — sometimes before these changes are evident on traditional paper-based tests. This article explores the science, clinical applications, and innovations driving this breakthrough.
Did you know that you can reduce your risk of developing dementia?
The risk of developing dementia is influenced by various factors, with several of them being modifiable by the actions we take on a daily basis. On this page you can learn more about what actions you can take to reduce your risk.
Our mission
PREDICTOM will identify scalable biosignatures for early and accurate diagnosis of Alzheimer’s disease and personalized preventive interventions.